CS
RCPI

Credit Suisse’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Credit Suisse’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-572
Closed -$3K – 4768
2014
Q4 		$3K Sell
572
-139
-20% -$731 ﹤0.01% 4563
2014
Q3 		$5K Sell
711
-19,129
-96% -$189K ﹤0.01% 4414
2014
Q2 		$293K Buy
+19,840
New +$344K ﹤0.01% 4123

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse's RCPI Position: Q1 2015 in Review

Credit Suisse sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q1 2015, closing a stake of 572 shares — an estimated $3K sold.

Credit Suisse first reported a position in RCPI in Q2 2014 and held it in 3 quarters. The position peaked at $293K in Q2 2014. 59 funds tracked by Wall St. Rank hold RCPI as of Q1 2015.

  • Credit Suisse reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Credit Suisse sold 572 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $3K.
  • Credit Suisse first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 3 quarters.
  • Credit Suisse's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $293K in Q2 2014.
  • 59 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.